A focus on the association of Apol1 with kidney disease in children

Pepe M. Ekulu, Agathe B. Nkoy, Oyindamola C. Adebayo, Orly K. Kazadi, Michel N. Aloni, Fanny O. Arcolino, Rene M. Ngiyulu, Jean Lambert E. Gini, François B. Lepira, Lamberthus P. Van den Heuvel, Elena N. Levtchenko

Research output: Contribution to journalReview articleAcademicpeer-review

12 Citations (Scopus)

Abstract

Individuals of African origin have an increased risk of developing various progressive chronic kidney diseases (CKD). This risk has been attributed to genetic variants (G1, G2) in apolipoprotein-L1 (APOL1) gene. In the pediatric population, especially in children affected by sickle cell disease (SCD), by human immunodeficiency virus (HIV), or with various glomerular diseases, APOL1 risk variants have been associated with the development of hypertension, albuminuria, and more rapid decline of kidney function. The present review focuses on existing APOL1-related epidemiological data in children with CKD. It also includes data from studies addressing racial disparities in CKD, the APOL1-related innate immunity, and the relationship between APOL1 and CKD and pathogenic pathways mediating APOL1-related kidney injury.

Original languageEnglish
Pages (from-to)777-788
Number of pages12
JournalPediatric Nephrology
Volume36
Issue number4
DOIs
Publication statusPublished - Apr 2021
Externally publishedYes

Keywords

  • APOL1
  • Children
  • Chronic kidney disease
  • Genetics
  • HIV-associated nephropathy
  • Sickle cell disease

Cite this